Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)
Net Income Growth
-30.32%
TTM · Period ending:
BIO Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-30.32%period ending
Latest reported-30.32%period ending
BIO TTM Net Income YoY % (35.19% → -30.32%)
Year-over-year change
High-resolution chart · PNG
BIO net income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Net Income Growth |
|---|---|
| 3,726.4836% | |
| 828.2933% | |
| 163.5593% | |
| -63.4422% | |
| -95.8185% | |
| -84.962% | |
| -51.4403% | |
| 52.3316% | |
| 35% | |
| 48.5876% | |
| 48.1707% | |
| 10.2857% | |
| -7.4074% | |
| -26.8595% | |
| -37.4046% | |
| -41.4716% | |
| -21.7391% | |
| -9.0226% | |
| 3.9683% | |
| 28.8793% | |
| 21.5859% | |
| 40% | |
| 61.5385% | |
| 118.8679% | |
| 233.8235% | |
| 352.381% | |
| 477.7778% | |
| 116.3265% | |
| -2.8571% | |
| -72.549% | |
| -82.6923% | |
| -68.7898% | |
| -53.9474% | |
| 88.8889% | |
| 90.2439% | |
| 55.4455% | |
| 52% | |
| -24.2991% | |
| -23.3645% | |
| 0% | |
| 1.0101% | |
| 1.9048% | |
| 5.9406% | |
| 9.7826% | |
| 2.0619% | |
| 8.2474% | |
| 5.2083% | |
| -1.0753% | |
| 8.9888% | |
| 12.7907% | |
| 23.0769% | |
| 24% | |
| 21.9178% | |
| 30.303% | |
| 30% | |
| 36.3636% | |
| 35.1852% |